Correlation Between Pulmatrix and Evoke Pharma

Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Evoke Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Evoke Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pulmatrix and Evoke Pharma, you can compare the effects of market volatilities on Pulmatrix and Evoke Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Evoke Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Evoke Pharma.

Diversification Opportunities for Pulmatrix and Evoke Pharma

-0.33

Correlation Coefficient

Pulmatrix  Evoke Pharma

Very good diversification

The 3 months correlation between Pulmatrix and Evoke is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Evoke Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evoke Pharma and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Evoke Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evoke Pharma has no effect on the direction of Pulmatrix i.e., Pulmatrix and Evoke Pharma go up and down completely randomly.

Pair Corralation between Pulmatrix and Evoke Pharma

Given the investment horizon of 90 days Pulmatrix is expected to under-perform the Evoke Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Pulmatrix is 4.29 times less risky than Evoke Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The Evoke Pharma is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  330.00  in Evoke Pharma on May 6, 2025 and sell it today you would earn a total of  139.00  from holding Evoke Pharma or generate 42.12% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pulmatrix  vs.  Evoke Pharma

Pulmatrix

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pulmatrix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Evoke Pharma

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Evoke Pharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent basic indicators, Evoke Pharma disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pulmatrix and Evoke Pharma

The main advantage of trading using opposite Pulmatrix and Evoke Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Evoke Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evoke Pharma will offset losses from the drop in Evoke Pharma's long position.

The idea behind Pulmatrix and Evoke Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.